Cargando…
Rituximab: Adenovirus pneumonia following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602538/ http://dx.doi.org/10.1007/s40278-021-05901-2 |
Ejemplares similares
-
Chloroquine/favipiravir/rituximab: COVID-19-pneumonia, off-label use and lack of efficacy: case report
Publicado: (2022) -
Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021) -
Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020) -
Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report
Publicado: (2022) -
Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)